Skip to main content
    P

    Pliant Therapeutics Inc (PLRX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.69
    -0.00 (-0.55%)

    Market Cap: $43.21M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    46%(12/26)
    Avg Surprise
    -1.33%

    Upcoming Estimates

    Reports Mar 9, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.38
    Range-$0.38 - -$0.38
    6 analysts
    Revenue Consensus
    N/A
    RangeN/A
    4 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.39
    Range-$0.39 - -$0.39
    1 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.39-1.3%
    60d ago-$0.38-2.6%
    30d ago-$0.38-2.6%
    7d ago-$0.39-1.3%
    Current-$0.39
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-50.30%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio8.05xQuick Ratio8.05x
    Trading Statistics
    Beta1.36Avg Volume351.46K
    52-Week High$1.6752-Week Low$0.69

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 28.2% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 21.2, below 30, the oversold line.

    Moving Averages

    SMA 10$0.78
    SMA 20$0.83
    SMA 50$0.97
    SMA 200$1.14
    EMA 10$0.77
    EMA 20$0.82
    EMA 50$0.92
    EMA 200$1.12

    MACD

    Line: -0.07Signal: -0.06Hist: -0.01

    ADX

    ADX: 42.5+DI: 8.1-DI: 33.1

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$0.79

    Bollinger Bands

    Upper Band$0.95
    Lower Band$0.70
    %B Position2953%(Upper)
    Band Width-0.04

    RSI (14-Day)

    Oversold
    21.2

    Momentum Oscillators

    Stoch %K7.1
    Stoch %D7.7
    Williams %R-86.3
    ROC (10d)-17.4%
    Momentum-0.15
    CCI (20d)-201.1
    MFI (14d)10.4

    Volatility Measures

    ATR (14d)$0.05(6.6%)
    StdDev (20d)0.06
    Hist Vol37.8%(Moderate)

    Volume Flow

    VWAP$0.69
    OBV-25.6M
    AD Line-36.9M
    CMF (20d)-0.231

    Volume Metrics

    Avg Vol (20d)354.4K
    Vol Ratio2.8x(High)
    VWMA (20d)$0.80

    Pivot Points

    R3$0.80
    R2$0.78
    R1$0.74
    Pivot Point$0.71
    S1$0.67
    S2$0.65
    S3$0.61

    Advanced Oscillators

    TSI-43.03
    Ultimate Osc35.7
    KST-196.32

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about PLRX

    News

    PLRX Valuation

    PLRX Profitability: Margins, ROIC and FCF

    Pliant Therapeutics (PLRX) has an operating margin of 0.0% and a net margin of 0.0%.

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -50.3%
    PLRX financial statements

    Pliant Therapeutics Competitors

    The companies most similar to Pliant Therapeutics (PLRX) include Pelthos Therapeutics, Plus Therapeutics and Gain Therapeutics.

    Sector: Healthcare

    Companies most similar to Pliant Therapeutics

    PLRX Analyst Ratings

    Pliant Therapeutics (PLRX) has a Sell consensus from 4 analysts: 0 Buy or Strong Buy, 3 Hold and 1 Sell or Strong Sell.

    Consensus
    Sell
    Analysts
    4
    Strong Buy
    0
    Buy
    0
    Hold
    3
    Sell
    0
    Strong Sell
    1
    PLRX stock forecast

    PLRX Bull Case vs Bear Case

    Bear case

    • PLRX's quarterly revenue changed -100.0% year over year.

    PLRX Earnings: Beat Rate and Next Report

    Pliant Therapeutics (PLRX) beat the EPS estimate in 4 of the last 8 quarters (50.0%). Its next report is expected on Mar 9, 2027.

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    0.7%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$0.38
    PLRX earnings history

    PLRX Earnings Date

    PLRX reports Mar 9, 2027. The date is estimated.

    See insider activity

    Updated Nov 12, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About PLRX

    When does PLRX report earnings?

    Pliant Therapeutics Inc (PLRX) is expected to report earnings on Mar 9, 2027.

    Does PLRX pay dividends?

    Pliant Therapeutics Inc (PLRX) does not currently pay a regular dividend.

    What is PLRX's market cap?

    Pliant Therapeutics Inc (PLRX) has a market capitalization of $43.21M with a current stock price of $0.69.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.